Industry Background:
The increasing incidence of mycoplasma contamination, as well as increasing research and development activities, will help to boost global Mycoplasma Testing market in the forecasted period. Mycoplasma testing is mainly used to help determine if Mycoplasma pneumonia is the cause of a respiratory tract infection. Also, It used to help diagnose a systemic infection that is thought to be due to mycoplasma. In the biotechnology sector, they are growing used for drug screening and development, and large-scale manufacturing of biological compounds.
According to AMA, the market for Mycoplasma Testing is expected to register a CAGR of 12.5% during the forecast period to 2026. This growth is primarily driven by Government Support for Pharma as well as Biotech Industry and Technological Advancement in Mycoplasma Testing.
Globally, a noticeable market trend is evident High Demand Due to Cell Culture Contamination
. The Diseases & Therapeutic Areas sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Thermo Fisher Scientific Inc. (United States), Charles River Laboratories International, Inc. (United States), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche Diagnostics (Switzerland), SGS S.A. (Switzerland), American Type Culture Collection (United States), Bionique Testing Laboratories, Inc. (United States), InvivoGen (United States) and PromoCell GmbH (Germany) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
On 14th March 2019, Lonza Expands Mycoplasma Detection Portfolio with New Luminometer Designed to Accelerate and Simplify Testing. The expansion of the portfolio with the new Lucetta™ 2 Luminometer establishes Lonza as the leading provider of fast, simple and accurate mycoplasma detection solutions,
On 10th July 2018, ATCC, the premier global biological materials resource and standards organization and the leading supplier of authenticated cells and advanced cell models, has announced the availability of its new PCR-based service to detect mycoplasma contamination in cell cultures.
Market Drivers
- Government Support for Pharma as well as Biotech Industry
- Technological Advancement in Mycoplasma Testing
Market Trend
- High Demand Due to Cell Culture Contamination
- Huge R&D Investments in Life Sciences
Restraints
- Stringent Government Regulations
- Growing Concern Regarding High Degree of Consolidation Acts for New Entrants
Opportunities
Huge Potential for Pharmaceuticals Outsourcing
Challenges
Dearth Of Skilled Workforce
AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Mycoplasma Testing Study Sheds Light on
The Mycoplasma Testing Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Mycoplasma Testing industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Mycoplasma Testing industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.